An in vitro and in vivo study of a BrdU-sensitive fragile site in the Chinese hamster.
The frequencies of chromosome aberrations and development of the bromodeoxyuridine (BrdU)-sensitive fragile site were studied in vitro in Chinese hamster kidney and bone marrow cells and in vivo in Chinese hamster bone marrow cells. Chromosome aberrations in these cell systems were measured in response to different concentrations of BrdU, fluorodeoxyuridine, or both. The fragile site was found in both homologues of chromosome 1 at 1q22. Treatment with BrdU in vitro but not in vivo produces significant chromosome aberrations. About 50% of chromosome aberrations found after treatment in vitro were at the BrdU-sensitive fragile site compared with 12.5% after treatment in vivo. These results show that BrdU is much more potent in vitro than in vivo in inducing both chromosome aberrations and the expression of the BrdU-sensitive site.
D000818:Animals; D001853:Bone Marrow; D001973:Bromodeoxyuridine / Q000494:pharmacology*; D002478:Cells, Cultured; D002869:Chromosome Aberrations; D002871:Chromosome Banding; D043283:Chromosome Fragile Sites; D002873:Chromosome Fragility; D006224:Cricetinae / Q000235:genetics*; D003412:Cricetulus / Q000235:genetics*; D005467:Floxuridine / Q000494:pharmacology; D007668:Kidney
D005467:Floxuridine; D001973:Bromodeoxyuridine